Merck's Keytruda Receives Traditional Approval for Type of Gastric Cancer

Seeking AlphaMar 19 14:05 ET

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

BenzingaMar 19 13:09 ET

Roche Re-Scopes Chief Diversity Offices to Comply With US Executive Orders on Diversity, Equity, Inclusion

MT NewswiresMar 19 09:25 ET

Trump's DEI Battle Goes Global as Swiss Drugs Group Roche (RHHBY) Terminates Targets

TipRanksMar 19 08:44 ET

Market Chatter: Roche Reportedly Scraps Global Diversity Targets

MT NewswiresMar 19 08:18 ET

Roche, Oxford BioTherapeutics Team Up for Antibody-based Cancer Therapy Development

MT NewswiresMar 19 05:55 ET

Roche Holding AG (RHHVF) Receives a Buy From Kepler Capital

TipRanksMar 18 21:37 ET · Ratings

Sarepta Safety Update on Elevidys Boosts Regenxbio, Hurts Solid Bio

Seeking AlphaMar 18 15:22 ET

Sarepta Plunges After Death Linked to Elevidys

Seeking AlphaMar 18 08:17 ET

Roche (RHHBY.US) oral PI3Kα inhibitor "Inalise" has been approved for sale in China.

On March 14, Roche (RHHBY.US) announced that the PI3Kα inhibitor "Inalise" has been approved for market.

Zhitong FinanceMar 13 22:49 ET

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Zacks Mar 13 13:20 ET

FDA Commissioner Nominee Makary Advances to Full Senate Vote

Seeking AlphaMar 13 10:58 ET

Trump's Chips War Has Left Intel's New CEO With a -2-

Barron'sMar 13 06:58 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Beam Therapeutics (BEAM)

TipRanksMar 13 05:20 ET · Ratings

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

WSJMar 13 03:46 ET

Bernstein Sticks to Its Buy Rating for Roche Holding AG (RHHVF)

TipRanksMar 12 11:05 ET · Ratings

Novo Nordisk Stock Dips as Roche Licenses Rival Weight-Loss Drug

Barron'sMar 12 10:32 ET · Movers

RHHBY Enters Into a $5.3B Deal With Zealand Pharma for Obesity Drug

Zacks Mar 12 09:00 ET

Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. -- Barrons.com

Barron'sMar 12 08:53 ET

BofA Global Research Keeps Roche at Buy After 'Compelling' $5.3 Billion Zealand Pharma Deal

MT NewswiresMar 12 07:43 ET